Table 4.

Procedure-related complications.

Complications	N(%)
Localized hematoma	5(7.4%)
Intraabdominal bleeding	6(8.8%)
Bile duct bleeding	1(1.5%)
Tumor rupture	0(0.0%)
ALT/AST increasing†	30(44.1%)
Bilirubin increasing	14(20.6%)
Acute liver failure	1(1.5%)
HE†
I-II	6(8.8%)
III-IV	3(4.4%)

Note:1. A LT, alanine transaminase; AST, aspartate aminotransferase; 2. HE. hepatic encephalopathy.